• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白癜风预后的临床预测因素

Clinical predictors of outcome in vitiligo.

作者信息

Dave Shriya, Thappa Devinder Mohan, Dsouza Mariette

机构信息

Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry-605 006, India.

出版信息

Indian J Dermatol Venereol Leprol. 2002 Nov-Dec;68(6):323-5.

PMID:17656989
Abstract

The significant inter-patient variability in progression, and response to therapy makes it a great challenge for the physician to predict the outcome of vitiligo at the very outset. Subjective factors like stress, pregnancy, sunburn and illness have been identified as aggravating factors for vitiligo. However, a few studies have evaluated the statistical significance of objective clinical parameters in predicting the outcome of vitiligo. Our retrospective analysis of 199 consecutive patients with vitiligo who presented to our OPD was aimed at evaluation of these objective clinical parameters utilizing a standard proforma. Patients already on treatment, and those with duration of disease less than 6 months were excluded from the study. Progression was defined as an increase in size or number of lesions in the 3 months prior to presentation. In all 76.9% patients had progression of vitiligo. The clinical parameters significantly associated with progression were a positive family history (p=0.027), mucosal involvement (p=0.032), Koebner's phenomenon (p=0.036) and nonsegmental vitiligo (p=0.033). Thrichrome sign, leucotrichia, longer duration and higher age at onset did not correlate significantly with progression. The one significant observation that we found to have the poor prognostic implication in vitiligo is the presence of mucosal vitiligo. The clinical prediction of disease progression at the outset enables the physician to set realistic treatment goals and optimize the therapeutic regimen for the individual patient.

摘要

患者在病情进展和对治疗反应方面存在显著的个体差异,这使得医生在疾病初期预测白癜风的预后成为一项巨大挑战。压力、怀孕、晒伤和疾病等主观因素已被确定为白癜风的加重因素。然而,少数研究评估了客观临床参数在预测白癜风预后方面的统计学意义。我们对连续199例到门诊就诊的白癜风患者进行回顾性分析,旨在使用标准表格评估这些客观临床参数。已接受治疗的患者以及病程少于6个月的患者被排除在研究之外。病情进展定义为就诊前3个月内皮损大小或数量增加。所有患者中,76.9%有白癜风进展。与病情进展显著相关的临床参数为阳性家族史(p = 0.027)、黏膜受累(p = 0.032)、同形反应(p = 0.036)和非节段性白癜风(p = 0.033)。三色征、白发、病程较长和发病年龄较大与病情进展无显著相关性。我们发现白癜风中一个具有不良预后意义的重要观察结果是黏膜白癜风的存在。在疾病初期对病情进展进行临床预测可使医生设定现实的治疗目标并为个体患者优化治疗方案。

相似文献

1
Clinical predictors of outcome in vitiligo.白癜风预后的临床预测因素
Indian J Dermatol Venereol Leprol. 2002 Nov-Dec;68(6):323-5.
2
Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study.节段性和非节段性儿童白癜风具有不同的临床特征:一项前瞻性观察研究。
J Am Acad Dermatol. 2010 Jun;62(6):945-9. doi: 10.1016/j.jaad.2009.06.081.
3
Clinical characteristics of progressive vitiligo.进展期白癜风的临床特征
Int J Dermatol. 1997 May;36(5):353-5. doi: 10.1046/j.1365-4362.1997.00162.x.
4
Late onset vitiligo: a study of 182 patients.迟发性白癜风:182例患者的研究
Int J Dermatol. 2005 Mar;44(3):193-6. doi: 10.1111/j.1365-4632.2004.01948.x.
5
Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.对影响白癜风临床反应的变异进行批判性评估:60例窄谱中波紫外线光疗患者的研究
J Eur Acad Dermatol Venereol. 2007 Nov;21(10):1369-74. doi: 10.1111/j.1468-3083.2007.02278.x.
6
Topical pimecrolimus: a new horizon for vitiligo treatment?外用吡美莫司:白癜风治疗的新前景?
J Dermatolog Treat. 2006;17(6):338-42. doi: 10.1080/09546630601028711.
7
Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.抗氧化剂与窄谱中波紫外线治疗白癜风:一项双盲安慰剂对照试验
Clin Exp Dermatol. 2007 Nov;32(6):631-6. doi: 10.1111/j.1365-2230.2007.02514.x.
8
Clinical profiles of vitiligo in China: an analysis of 3742 patients.中国白癜风临床特征:3742例患者分析
Clin Exp Dermatol. 2005 Jul;30(4):327-31. doi: 10.1111/j.1365-2230.2005.01813.x.
9
Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo.评估外用他卡西醇与日光照射治疗成人非节段型白癜风疗效的随机双盲临床试验
Br J Dermatol. 2009 Feb;160(2):409-14. doi: 10.1111/j.1365-2133.2008.08906.x. Epub 2008 Oct 21.
10
The relationship between family medical history and childhood vitiligo.家族病史与儿童白癜风之间的关系。
J Am Acad Dermatol. 2006 Aug;55(2):238-44. doi: 10.1016/j.jaad.2006.02.027. Epub 2006 May 18.

引用本文的文献

1
Clinico-Epidemiological Profile and Treatment Pattern of Vitiligo in Selected Dermatological Clinics of Mekelle City, Northern Ethiopia.埃塞俄比亚北部默克莱市部分皮肤科诊所白癜风的临床流行病学特征及治疗模式
Dermatol Res Pract. 2020 May 30;2020:3625753. doi: 10.1155/2020/3625753. eCollection 2020.
2
A Clinical Study of Vitiligo in a Rural Set up of Gujarat.古吉拉特邦农村地区白癜风的临床研究
Indian J Community Med. 2014 Jul;39(3):143-6. doi: 10.4103/0970-0218.137150.
3
Gender differences in clinicoepidemiological features of vitiligo: a cross-sectional analysis.
白癜风临床流行病学特征的性别差异:一项横断面分析
ISRN Dermatol. 2014 Feb 13;2014:186197. doi: 10.1155/2014/186197. eCollection 2014.
4
Clinical patterns of vitiligo and its associated co morbidities: A prospective controlled cross-sectional study in South India.白癜风的临床模式及其相关合并症:印度南部的一项前瞻性对照横断面研究。
Indian Dermatol Online J. 2012 May;3(2):114-8. doi: 10.4103/2229-5178.96705.
5
Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people.汉族人白癜风中诱导型一氧化氮合酶基因多态性分析。
PLoS One. 2011;6(12):e27077. doi: 10.1371/journal.pone.0027077. Epub 2011 Dec 21.